The Chinese Center for disease Control and Prevention (China CDC) early proposed the use of IFN-α-2b to treat COVID-19, as it has been historically used in China to treat viral pneumonia associated with SARS-Cov and middle east respiratory syndrome coronavirus (MERS). Here, IFNA2 is linked to COVID-19.